Overview

The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker

Status:
Unknown status

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

1. Treatment of Hypercholesterolemic patients with niacin will cause a significant decrease in oxidative stress and a decrease in the atherogenecity in blood samples of the patients. 2. A possible correlation between oxidative stress in hypercholesterolemic patients taking niacin to clinical hypercholesterolemia parameters is possible. 3. Using a novel biomarker will enable a precise detection of the change in the oxidative stress in hypercholesterolemic patients.

Phase:

Phase 3

Details

Lead Sponsor:

Rambam Health Care Campus

Treatments:

Niacin
Niacinamide
Nicotinic Acids